Cargando…

Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4(+) T Cell Activation and Mycobacterium tuberculosis Control

Tuberculosis (TB) is one of the leading causes of death due to a single infectious agent. The development of a TB vaccine that induces durable and effective immunity to Mycobacterium tuberculosis (Mtb) infection is urgently needed. Early and superior Mtb control can be induced in M. bovis Bacillus C...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Shibali, Marin, Nancy D., Esaulova, Ekaterina, Ahmed, Mushtaq, Swain, Amanda, Rosa, Bruce A., Mitreva, Makedonka, Rangel-Moreno, Javier, Netea, Mihai G., Barreiro, Luis B., Divangahi, Maziar, Artyomov, Maxim N., Kaushal, Deepak, Khader, Shabaana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406195/
https://www.ncbi.nlm.nih.gov/pubmed/34253059
http://dx.doi.org/10.1128/mBio.01468-21
Descripción
Sumario:Tuberculosis (TB) is one of the leading causes of death due to a single infectious agent. The development of a TB vaccine that induces durable and effective immunity to Mycobacterium tuberculosis (Mtb) infection is urgently needed. Early and superior Mtb control can be induced in M. bovis Bacillus Calmette-Guérin (BCG)-vaccinated hosts when the innate immune response is targeted to generate effective vaccine-induced immunity. In the present study, we show that innate activation of DCs is critical for mucosal localization of clonally activated vaccine-induced CD4(+) T cells in the lung and superior early Mtb control. In addition, our study reveals that Th1/Th17 cytokine axis play an important role in superior vaccine-induced immunity. Our studies also show that activation of the nuclear factor kappa-light-chain enhancer of activated B cell (NF-κβ) pathway in lung epithelial cells is critical for the mucosal localization of activated vaccine-induced CD4(+) T cells for rapid Mtb control. Thus, our study provides novel insights into the immune mechanisms that can overcome TB vaccine bottlenecks and provide early rapid Mtb control.